FCMI
AERI

Foresite Capital Management II’s Aerie Pharmaceuticals AERI Stock Holding History

Foresite Capital Management II’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-253,698
Closed -$3.42M – 6
2020
Q1 		$3.42M Sell
253,698
-1,419,016
-85% -$26.9M 0.8% 4
2019
Q4 		$40.4M Hold
1,672,714
– – 6.66% 2
2019
Q3 		$32.1M Hold
1,672,714
– – 6.8% 3
2019
Q2 		$49.4M Hold
1,672,714
– – 27.79% 2
2019
Q1 		$79.5M Hold
1,672,714
– – 35.87% 1
2018
Q4 		$60.4M Buy
1,672,714
+207,965
+14% +$9.76M 32% 2
2018
Q3 		$90.2M Hold
1,464,749
– – 33.37% 1
2018
Q2 		$98.9M Sell
1,464,749
-207,965
-12% -$11.6M 34.86% 1
2018
Q1 		$90.7M Hold
1,672,714
– – 30.19% 2
2017
Q4 		$99.9M Hold
1,672,714
– – 34.92% 2
2017
Q3 		$81.3M Hold
1,672,714
– – 32.95% 2
2017
Q2 		$87.9M Buy
1,672,714
+99,688
+6% +$4.64M 40.27% 1
2017
Q1 		$71.3M Sell
1,573,026
-1,723
-0.1% -$76.8K 30.6% 2
2016
Q4 		$59.6M Sell
1,574,749
-97,965
-6% -$3.7M 29.91% 2
2016
Q3 		$63.1M Buy
1,672,714
+697,429
+72% +$15.4M 30.14% 1
2016
Q2 		$17.2M Buy
975,285
+25,913
+3% +$419K 11.73% 3
2016
Q1 		$11.5M Buy
949,372
+211,011
+29% +$3.34M 5.65% 8
2015
Q4 		$18M Sell
738,361
-167,956
-19% -$3.92M 6.03% 6
2015
Q3 		$16.1M Buy
906,317
+101,100
+13% +$1.83M 4.88% 6
2015
Q2 		$14.2M Buy
805,217
+595,150
+283% +$10.9M 4.99% 8
2015
Q1 		$6.58M Sell
210,067
-10,000
-5% -$290K 3.9% 6
2014
Q4 		$6.42M Buy
+220,067
New +$5.58M 4.4% 7

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Foresite Capital Management II's AERI Position: Q2 2020 in Review

Foresite Capital Management II sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 253,698 shares — an estimated $3.42M sold.

Foresite Capital Management II first reported a position in AERI in Q4 2014 and held it in 22 quarters. The position peaked at $99.9M in Q4 2017. 154 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Foresite Capital Management II reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Foresite Capital Management II sold 253,698 Aerie Pharmaceuticals shares in Q2 2020, an estimated $3.42M.
  • Foresite Capital Management II first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 22 quarters.
  • Foresite Capital Management II's Aerie Pharmaceuticals position peaked at $99.9M in Q4 2017.
  • 154 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Foresite Capital Management II's 13F filing for Q2 2020, filed 13 Aug 2020.